New platform combines precision gene targeting with brain-wide delivery
The platform overcomes a key obstacle to delivering gene therapies throughout the brain.
Read the full articleYou might also wanna read
Study uses brain's glymphatic system to deliver gene therapy across blood-brain barrier
A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors t
news-medical.net·2d agoEngineered AAVs Bypass Blood-Brain Barrier via Glymphatic System in Mice
Scientists demonstrate a novel AAV delivery strategy using the brain's glymphatic system to target glial cells, potentially enabling future
Engineered AAVs Harness Glymphatic System to Reach Brain Targets in Mice
By delivering engineered adeno-associated viruses through the brain's fluid transport network to target glial cells, scientists demonstrated
Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
Consultants from ProPharma express optimism about the trajectory of cell and gene therapy despite technical and logistical difficulties rema
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies
Neuronopathic Gaucher disease (nGD) is a lysosomal storage disorder caused by GBA1 mutations, leading to defective acid β-glucosidase (GCase
Advances in Brain-on-a-Chip and BBB-on-a-Chip Models for Neurodegenerative Disease Research
Brain-on-a-chip is a microphysiologic platform that comprises cultured brain cells to understand brain disease pathogenesis and treatment. T
journals.sagepub.com·17d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.